XBiotech Inc. financial data

Symbol
XBIT on Nasdaq
Location
5217 Winnebago Lane, Austin, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.67K % -5.45%
Debt-to-equity 6.55 % +6.5%
Return On Equity -15.6 % +5.57%
Return On Assets -14.6 % +5.98%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5M shares +0.08%
Common Stock, Shares, Outstanding 30.5M shares +0.08%
Entity Public Float 122M USD -13.2%
Common Stock, Value, Issued 277M USD +1.66%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares +0.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 31.9M USD -16.4%
General and Administrative Expense 4.64M USD -2.73%
Operating Income (Loss) -36.5M USD +14.9%
Nonoperating Income (Expense) 8.4M USD +3.33%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -28.1M USD +19.1%
Income Tax Expense (Benefit) 25K USD -81.6%
Net Income (Loss) Attributable to Parent -28.2M USD +19.6%
Earnings Per Share, Basic 0 USD/shares +20%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 153M USD -18.9%
Accounts Receivable, after Allowance for Credit Loss, Current 480K USD -44.8%
Assets, Current 155M USD -18.8%
Property, Plant and Equipment, Net 23.8M USD -4.51%
Assets 179M USD -17.1%
Accounts Payable, Current 1.43M USD -16%
Employee-related Liabilities, Current 611K USD +8.72%
Accrued Liabilities, Current 2.41M USD -54.9%
Liabilities, Current 3.86M USD -77.5%
Accrued Income Taxes, Noncurrent 1.76M USD +2.44%
Deferred Income Tax Liabilities, Net 0 USD -100%
Liabilities 5.62M USD -70.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -103M USD -37.4%
Stockholders' Equity Attributable to Parent 173M USD -12%
Liabilities and Equity 179M USD -17.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.72M USD +6.69%
Net Cash Provided by (Used in) Financing Activities -10.3M USD -202%
Net Cash Provided by (Used in) Investing Activities -94K USD +63.1%
Common Stock, Shares, Issued 30.5M shares +0.17%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.8M USD -1752%
Interest Paid, Excluding Capitalized Interest, Operating Activities 486K USD +21.5%
Deferred Tax Assets, Valuation Allowance 26.4M USD +50.1%
Deferred Tax Assets, Gross 26.8M USD +47.1%
Depreciation 442K USD +2.32%
Payments to Acquire Property, Plant, and Equipment 94K USD -63.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.5M USD -51.8%
Deferred Tax Assets, Operating Loss Carryforwards 2.8M USD +117%
Unrecognized Tax Benefits 3.43M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 395K USD -37.1%
Share-based Payment Arrangement, Expense 4.43M USD +84.3%